Condition
IGF1 Deficiency
Total Trials
4
Recruiting
1
Active
1
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 100/100
Termination Rate
25.0%
1 terminated out of 4 trials
Success Rate
0.0%
-86.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
0
Data Visualizations
Phase Distribution
2Total
Not Applicable (2)
Trial Status
Unknown2
Recruiting1
Terminated1
Clinical Trials (4)
Showing 4 of 4 trials
NCT00903110RecruitingPrimary
Global Patient Registry to Monitor Long-term Safety and Effectiveness of Increlex® in Children and Adolescents With Severe Primary Insulin-like Growth Factor-1 Deficiency (SPIGFD).
NCT05642169Not ApplicableUnknown
Effect of a HIIT Program on Quality of Life, Executive Functions, and IGF-1 Response in Sedentary Young University Women
NCT01676090TerminatedPrimary
IGF-1, IGFBP3, ALS Normative Ranges in Healthy Pediatric Spanish Population
NCT03275272Not ApplicableUnknownPrimary
Effect of Maternal BMI and Type of Infants Feeding on IGF-1 in Infant
Showing all 4 trials